tiprankstipranks
Wellgistics Health Inc (WGRX)
NASDAQ:WGRX
US Market
WGRX
Wellgistics Health Inc
RESEARCH TOOLSreports
Want to see WGRX full AI Analyst Report?

Wellgistics Health Inc (WGRX) Ratios

185 Followers

Wellgistics Health Inc Ratios

WGRX's free cash flow for Q4 2025 was $-6.14. For the 2025 fiscal year, WGRX's free cash flow was decreased by $ and operating cash flow was $-7.67. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 0.09 0.09 0.40 0.12
Quick Ratio
 0.04 0.04 0.15 0.12
Cash Ratio
 <0.01 <0.01 0.03 <0.01
Solvency Ratio
 -2.29 -2.29 -0.11 -0.89
Operating Cash Flow Ratio
 -0.36 -0.36 -0.03 -0.12
Short-Term Operating Cash Flow Coverage
 -0.95 -0.95 -0.10 -1.00
Net Current Asset Value
$ -40.09M$ -40.09M$ -35.43M$ -2.90M
Leverage Ratios
Debt-to-Assets Ratio
 0.81 0.81 0.44 2.07
Debt-to-Equity Ratio
 -1.97 -1.97 3.73 -0.24
Debt-to-Capital Ratio
 2.03 2.03 0.79 -0.32
Long-Term Debt-to-Capital Ratio
 19.32 19.32 0.63 -0.14
Financial Leverage Ratio
 -2.45 -2.45 8.51 -0.12
Debt Service Coverage Ratio
 -4.86 -4.86 -0.38 -7.89
Interest Coverage Ratio
 -17.73 -17.73 -7.39 -191.01
Debt to Market Cap
 3.21 0.87 0.12 <0.01
Interest Debt Per Share
 0.41 0.41 0.50 0.02
Net Debt to EBITDA
 -0.31 -0.31 -4.90 -0.24
Profitability Margins
Gross Profit Margin
-41.30%-41.30%9.75%0.00%
EBIT Margin
-347.91%-347.91%-33.23%0.00%
EBITDA Margin
-334.15%-334.15%-27.08%0.00%
Operating Profit Margin
-347.91%-347.91%-33.90%0.00%
Pretax Profit Margin
-433.95%-433.95%-37.82%0.00%
Net Profit Margin
-433.95%-433.95%-37.82%0.00%
Continuous Operations Profit Margin
-433.95%-433.95%-37.82%0.00%
Net Income Per EBT
100.00%100.00%100.00%100.00%
EBT Per EBIT
124.73%124.73%111.57%100.52%
Return on Assets (ROA)
-332.49%-332.49%-11.96%-855.79%
Return on Equity (ROE)
141760.17%813.59%-101.81%99.84%
Return on Capital Employed (ROCE)
-11952.35%-11952.35%-31.86%112.95%
Return on Invested Capital (ROIC)
-669.04%-669.04%-19.30%130.91%
Return on Tangible Assets
-1701.85%-1701.85%-36.57%-855.79%
Earnings Yield
-1323.45%-357.12%-3.46%-1.70%
Efficiency Ratios
Receivables Turnover
 20.52 20.52 4.84 0.00
Payables Turnover
 2.83 2.83 2.58 0.00
Inventory Turnover
 20.11 20.11 1.72 0.00
Fixed Asset Turnover
 19.51 19.51 9.46 0.00
Asset Turnover
 0.77 0.77 0.32 0.00
Working Capital Turnover Ratio
 -1.00 -0.94 -1.43 0.00
Cash Conversion Cycle
 -93.19 -93.19 146.45 0.00
Days of Sales Outstanding
 17.79 17.79 75.42 0.00
Days of Inventory Outstanding
 18.15 18.15 212.35 0.00
Days of Payables Outstanding
 129.12 129.12 141.31 0.00
Operating Cycle
 35.93 35.93 287.76 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.15 -0.15 -0.02 >-0.01
Free Cash Flow Per Share
 -0.15 -0.15 -0.03 >-0.01
CapEx Per Share
 <0.01 0.00 <0.01 0.00
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.31 1.00
Dividend Paid and CapEx Coverage Ratio
 -3.62M 0.00 -3.25 0.00
Capital Expenditure Coverage Ratio
 -3.62M 0.00 -3.25 0.00
Operating Cash Flow Coverage Ratio
 -0.44 -0.44 -0.05 -0.50
Operating Cash Flow to Sales Ratio
 -0.47 -0.47 -0.07 0.00
Free Cash Flow Yield
-141.95%-38.28%-0.81%-0.20%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -0.08 -0.28 -28.87 -58.84
Price-to-Sales (P/S) Ratio
 0.33 1.22 10.92 0.00
Price-to-Book (P/B) Ratio
 -0.61 -2.28 29.39 -58.74
Price-to-Free Cash Flow (P/FCF) Ratio
 -0.70 -2.61 -123.52 -488.01
Price-to-Operating Cash Flow Ratio
 -0.70 -2.61 -161.56 -488.01
Price-to-Earnings Growth (PEG) Ratio
 <0.01 >-0.01 -0.25 -17.99
Price-to-Fair Value
 -0.61 -2.28 29.39 -58.74
Enterprise Value Multiple
 -0.41 -0.68 -45.21 -59.39
Enterprise Value
 32.19M 52.90M 221.99M 171.08M
EV to EBITDA
 -0.41 -0.68 -45.21 -59.39
EV to Sales
 1.38 2.27 12.25 0.00
EV to Free Cash Flow
 -2.97 -4.87 -138.55 -490.01
EV to Operating Cash Flow
 -2.97 -4.87 -181.22 -490.01
Tangible Book Value Per Share
 -0.52 -0.52 -0.61 -0.06
Shareholders’ Equity Per Share
 -0.18 -0.18 0.13 -0.06
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00
Revenue Per Share
 0.33 0.33 0.35 0.00
Net Income Per Share
 -1.43 -1.43 -0.13 -0.06
Tax Burden
 1.00 1.00 1.00 1.00
Interest Burden
 1.25 1.25 1.14 1.01
Research & Development to Revenue
 0.00 0.00 0.00 0.00
SG&A to Revenue
 3.07 3.07 0.37 0.00
Stock-Based Compensation to Revenue
 2.35 2.35 0.06 0.00
Income Quality
 0.11 0.11 0.18 0.12
Currency in USD